Form 8-K · Current report
General Dynamics 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0000040533
- Accession no.
- 0001193125-26-332899
Summary
General Dynamics filed a prospectus supplement on August 4, 2026 for an offer to rescind the acquisition of up to 1,010,925 shares of its common stock, and filed an 8-K providing Gibson, Dunn & Crutcher LLP's opinion on the shares' validity.
Key points
- General Dynamics filed a prospectus supplement on August 4, 2026 covering an offer to rescind the acquisition of up to 1,010,925 shares of its common stock.
- The prospectus supplement was filed under Rule 424(b)(5) pursuant to the company's automatic shelf registration statement on Form S-3 (File No. 333-297821), filed July 30, 2026.
- The 8-K was filed to provide the legal opinion of Gibson, Dunn & Crutcher LLP on the validity of the shares, attached as Exhibit 5.1 and incorporated by reference into the registration statement.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events On August 4, 2026, General Dynamics Corporation (the “Company”) filed a prospectus supplement, dated August 4, 2026 (the “Prospectus Supplement”), with the Securities and Exchange Commission (the “SEC”) pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended, relating to the Company’s offer to rescind (the “Rescission Offer”) the acquisition of up to 1,010,925 shares of the Company’s common stock, par value $1.00 per share (the “Shares”). The Prospectus Supplement was filed pursuant to the Company’s automatic shelf Registration Statement on Form S-3 (File No. 333-297821), filed with the SEC on July 30, 2026 (the “Registration Statement”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.